Publications

Submitted
“Letter to Editor”. Submitted. Web.
2022
Vitetta, Luis, et al. “Re: “Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial” by Crippa et al.”. Cannabis and Cannabinoid Research 72 (2022): 231–233. Web.
2021
Lindsay, Nicole Mercer, et al. “Brain circuits for pain and its treatment”. Science Translational Medicine 13.619 (2021): n. pag. Web.
Gilam, Gadi, et al. “Classifying chronic pain using multidimensional pain-agnostic symptom assessments and clustering analysis”. Science Advances 737 (2021): n. pag. Web.
Gilam, Gadi, et al. “Classifying chronic pain using multidimensional pain-agnostic symptom assessments and clustering analysis”. (2021): n. pag. Web.
Zhang, Jinxiao, et al. “Individual differences in perceived sleep quality do not predict negative affect reactivity or regulation”. Biological Psychology 164 (2021): 108149. Web.
Shany, Ofir, et al. “Somatic engagement alters subsequent neurobehavioral correlates of affective mentalizing”. Human Brain Mapping 42.18 (2021): 5846–5861. Web.
Banerjee, Shreya, et al. “Anandamide alters the membrane properties, halts the cell division and prevents drug efflux in multidrug resistant Staphylococcus aureus”. Scientific Reports 11.1 (2021): n. pag. Web.
Murillo-Rodr\'ıguez, Eric, et al. “Assessing the treatment of cannabidiolic acid methyl ester: a stable synthetic analogue of cannabidiolic acid on c-Fos and NeuN expression in the hypothalamus of rats”. Journal of Cannabis Research 31 (2021): n. pag. Web.
Di Bartolomeo, Martina, et al. “Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal $\upDelta$9-tetrahydrocannabinol-exposed rats”. Pharmacological Research 164 (2021): 105357. Web.
Sand, Daniel, et al. “Deep Brain Stimulation Can Differentiate Subregions of the Human Subthalamic Nucleus Area by EEG Biomarkers”. Frontiers in Systems Neuroscience 15 (2021): n. pag. Web.
Mor-Shaked, Hagar, et al. “Levodopa-responsive dystonia caused by biallelic $łess$i$\greater$PRKN$łess$/i$\greater$ exon inversion invisible to exome sequencing”. Brain Communications 33 (2021): n. pag. Web.
Sand, Daniel, et al. “Machine learning-based personalized subthalamic biomarkers predict ON-OFF levodopa states in Parkinson patients”. Journal of Neural Engineering 18.4 (2021): 046058. Web.
Iskhakova, L., et al. “Modulation of dopamine tone induces frequency shifts in cortico-basal ganglia beta oscillations”. Nature Communications 12.1 (2021): n. pag. Web.
Ayoub, Samantha M., et al. “Spontaneous and Naloxone-Precipitated Withdrawal Behaviors From Chronic Opiates are Accompanied by Changes in N-Oleoylglycine and N-Oleoylalanine Levels in the Brain and Ameliorated by Treatment With These Mediators”. Frontiers in Pharmacology 12 (2021): n. pag. Web.
Guang, Jing, et al. “Toward asleep DBS: cortico-basal ganglia spectral and coherence activity during interleaved propofol/ketamine sedation mimics NREM/REM sleep activity”. npj Parkinson\textquotesingles Disease 71 (2021): n. pag. Web.
Feldman, Mark, et al. “Anti-Biofilm Activity of Cannabidiol against Candida albicans”. Microorganisms 92 (2021): 441. Web.
Silva, Nicole Rodrigues, et al. “The Cannabidiol Analog PECS-101 Prevents Chemotherapy-Induced Neuropathic Pain via PPAR$\upgamma$ Receptors”. Neurotherapeutics (2021): n. pag. Web.
Rock, Erin M., et al. “N-Oleoylglycine and N-Oleoylalanine Do Not Modify Tolerance to Nociception, Hyperthermia, and Suppression of Activity Produced by Morphine”. Frontiers in Synaptic Neuroscience 13 (2021): n. pag. Web.
Kogan, Natalya M., et al. “Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity”. Molecules 26.18 (2021): 5601. Web.

Pages